GUANGZHOU, China, April 27, 2018 -- YY Inc. (Nasdaq:YY) (“YY” or the “Company”), a leading live streaming social media platform in China, announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2017 with the Securities and Exchange Commission on April 26, 2018. The annual report can be accessed on YY's investor relations website at http://ir.yy.com/. The Company will provide a hard copy of the annual report containing its audited consolidated financial statements, free of charge, to its shareholders and ADS holders upon request.
About YY Inc.
YY Inc. (“YY” or the “Company”) is a leading live streaming social media platform in China. The Company’s highly engaged users contribute to a vibrant social community by creating, sharing and enjoying a vast range of entertainment content and activities. YY enables users to interact with each other in real-time through online live media and offers users a uniquely engaging and immersive entertainment experience. YY Inc. was listed on the NASDAQ in November 2012.
Investor Relations Contact:
YY Inc.
Matthew Zhao
Tel: +86 (20) 8212-0000
Email: [email protected]
ICR, Inc.
Jack Wang
Tel: (+1) 646 915-1611
Email: [email protected]


KPMG Australia Cuts 5% of Workforce Amid Scandal
BNP Paribas, KB Kookmin Eye $2 Billion Techcombank Stake
J.P. Morgan Upgrades Diploma, Lifts Price Target to 8,250p
Trump Buys SpaceX Shares After Record IPO
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan
Ampol Profit Surges as Refining Margins Hit Record Highs
Australia’s Big Four Banks Face Mortgage Slowdown as Valuations Draw Scrutiny
OpenAI Data Center Chief Chris Malone Exits Ahead of Planned 2027 Listing
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Nvidia Options Price in $280 Billion Earnings Swing
Adidas, Puma Shares Fall as Dick’s Sporting Goods Cuts Outlook
Woodside Drops $5 Billion Clean Energy Plan as Profit Rises 7%
Xiaomi Unveils Xring O3 Chip for Flagship Foldable Phone
Samsung Shares Tumble 8% as $79 Billion Return Plan Disappoints
Hanmi Pharm Soars 30% on $2.3 Billion Genentech Obesity Drug Deal
Exxon, LyondellBasell Eye Shell’s $8 Billion U.S. Chemicals Assets
California Seeks Paramount Divestitures in Warner Bros. Merger 



